This week's View discusses key points from a Presidential Advisory about risk identification and reduction of CVD in women and important findings from a trial comparing the safety and efficacy of catheter ablation compared with drug therapy for the treatment of patients with atrial fibrillation.

Subscribe on iTunes | Subscribe on Google Play

Keywords: EaglesEyeView, Anticoagulants, Arrhythmias, Cardiac, Metabolic Syndrome, Dyslipidemias, Pericarditis, Primary Prevention, Secondary Prevention, Vascular Diseases, Atrial Fibrillation, Catheter Ablation, Drug Therapy, Heart Arrest, Hemorrhage, Pericardial Effusion, Pulmonary Veins, Stroke, Amenorrhea, Arthritis, Rheumatoid, Breast Neoplasms, Cardiac Rehabilitation, Cardiovascular Diseases, Contraceptives, Oral, Coronary Artery Disease, Diabetes Mellitus, Diabetes, Gestational, Diet, Dietary Fiber, Electronic Health Records, Exercise, Fenofibrate, Fertility, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hyperlipidemias, Hypertension, Hypertension, Pregnancy-Induced, Lupus Erythematosus, Systemic, Menopause, Obesity, Polycystic Ovary Syndrome, Postpartum Period, Pre-Eclampsia, Pregnancy, Risk Assessment, Risk Factors, Risk Reduction Behavior, Smoking, Stroke, Triglycerides, Weight Loss, Women

< Back to Listings